Skip to main content
logo
Balchem Corporation (BCPC)
NASDAQ: BCPC · Real-Time Price · USD
175.28
-0.42 (-0.24%)
Mar 6, 2026, 4:00 PM EST - Market closed

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
759.45M723.30M
United States Revenue Growth
5.00%4.89%
Foreign Countries Revenue
277.71M230.38M
Foreign Countries Revenue Growth
20.54%-1.05%
Revenue (Total)
1.04B953.68M
Revenue (Total) Growth
8.75%3.39%

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Human Nutrition and Health Revenue
659.39M600.26M
Human Nutrition and Health Revenue Growth
9.85%8.99%
Animal Nutrition and Health Revenue
230.85M214.71M
Animal Nutrition and Health Revenue Growth
7.52%-9.91%
Specialty Products Revenue
140.98M132.75M
Specialty Products Revenue Growth
6.20%5.39%
Other and Unallocated Business Segment Revenue
5.95M5.97M
Other and Unallocated Business Segment Revenue Growth
-0.35%-19.33%
Revenue (Total)
1.04B953.68M
Revenue (Total) Growth
8.75%3.39%

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Product Sales Revenue
1.04B951.95M
Product Sales Revenue Growth
8.75%3.48%
Royalty Revenue
1.89M1.74M
Royalty Revenue Growth
8.75%-30.19%
Revenue (Total)
1.04B953.68M
Revenue (Total) Growth
8.75%3.39%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Human Nutrition and Health Earnings From Operations
153.91M135.96M
Human Nutrition and Health Earnings From Operations Growth
13.20%32.75%
Animal Nutrition and Health Earnings From Operations
18.69M14.01M
Animal Nutrition and Health Earnings From Operations Growth
33.36%-49.18%
Specialty Products Earnings From Operations
42.90M39.91M
Specialty Products Earnings From Operations Growth
7.51%15.40%
Other and Unallocated Business Segment Earnings From Operations
-6.17M-6.97M
Operating Income (Total)
209.33M182.91M
Operating Income (Total) Growth
14.44%14.90%

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Human Nutrition and Health Backlog
39.59B39.96B
Human Nutrition and Health Backlog Growth
-0.93%23.26%
Animal Nutrition and Health Backlog
11.49B9.04B
Animal Nutrition and Health Backlog Growth
27.16%18.27%
Specialty Products Backlog
1.93B1.28B
Specialty Products Backlog Growth
50.54%-52.05%
Other Business Segment Backlog
356.00M137.00M
Other Business Segment Backlog Growth
159.85%-38.29%
Total Backlog
53.37B50.42B
Total Backlog Growth
5.85%17.36%
Updated Feb 20, 2026. Data Source: Fiscal.ai.